Ambeed.cn

首页 / / / / NNK

NNK {[allProObj[0].p_purity_real_show]}

货号:A522339

NNK 是一种尼古丁亚硝化衍生物,激活 ERK1/2和 PKCα,并在 Ser70 激活 Bcl2磷酸化,以及在 Thr58和 Ser62激活 c-Myc。NNK能够诱导人肺癌细胞的增殖和存活,用于构建肺癌小鼠模型。

HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
NNK 化学结构 CAS号:64091-91-4
NNK 化学结构
CAS号:64091-91-4
NNK 3D分子结构
CAS号:64091-91-4
NNK 化学结构 CAS号:64091-91-4
NNK 3D分子结构 CAS号:64091-91-4
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

NNK 纯度/质量文件 产品仅供科研

货号:A522339 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

NNK 生物活性

描述 NNK, a nitrosated derivative of nicotine, concurrently induces phosphorylation of Bcl2 uniquely at Ser70 and c-Myc at Thr58 and Ser62 via activation of both ERK1/2 and PKCα[1]. NNK promotes the survival and proliferation of human lung cancer cells and can be utilized in constructing lung cancer mouse models[2].
体外研究

NNK (100 pM; 0-60 min) triggers the activation of PKCα and MAPKs ERK1/2, which directly leads to c-Myc phosphorylation[1].

NNK (100 pM; 96 hours) boosts the proliferation of cells expressing wild-type (WT) but not the AA mutant of c-Myc[1].

NNK 细胞实验

Cell Line
Concentration Treated Time Description References
MLE-12 cells 10 µM 24 hours NNK significantly increased AGT protein expression. Exp Mol Med. 2023 Jun;55(6):1131-1144
DMS79 cells 10 µM 48 and 72 hours NNK treatment significantly increased DNMT1 expression Sci Rep. 2018 Mar 20;8(1):4903
A549 10 mM 12 hours NNK upregulated CD36 expression and promoted cell proliferation, migration, and invasion. iScience. 2023 Jul 27;26(8):107477
Bet1A 10 mM 12 hours NNK upregulated CD36 expression and promoted cell proliferation, migration, and invasion. iScience. 2023 Jul 27;26(8):107477
NCI-H23 10 mM 12 hours NNK upregulated CD36 expression and promoted cell proliferation, migration, and invasion. iScience. 2023 Jul 27;26(8):107477
Alveolar type II cells 0.1 µM and 1.2 µM 180 minutes To study the metabolism of NNK in the lung and the distribution of its metabolites, it was found that NNK is metabolized in the lung primarily through detoxification pathways, with approximately 55% of metabolites formed through detoxification pathways and roughly 30% through bioactivation pathways. Drug Metab Dispos. 2010 May;38(5):752-60
HBEL/p53i cells 10 µM 2 weeks NNK significantly increased foci formation, which was significantly abrogated by treatment with an ACE inhibitor or AGTR1 antagonist. Exp Mol Med. 2023 Jun;55(6):1131-1144
BEAS-2B cells 10 µM 24 hours NNK induced AGT expression and secretion of AngII, leading to the acquisition of transformed phenotypes in lung epithelial cells. Exp Mol Med. 2023 Jun;55(6):1131-1144
H1299 10 µM 24 hours NNK increased DNMT1 protein levels and resulted in hypermethylation of TSG promoters J Clin Invest. 2010 Feb;120(2):521-32
A549 10 µM 24 hours NNK increased DNMT1 protein levels and resulted in hypermethylation of TSG promoters J Clin Invest. 2010 Feb;120(2):521-32
IMR90 10 µM 24 hours NNK increased DNMT1 protein levels and resulted in hypermethylation of TSG promoters J Clin Invest. 2010 Feb;120(2):521-32
BEAS-2B cells 50, 100, 200 mg/L 24 hours To detect the expression level of RRM2-C2orf48 in BEAS-2B cells after NNK treatment, results showed that 200 mg/L dose significantly upregulated RRM2-C2orf48 expression iScience. 2022 Dec 2;26(1):105708
BEAS-2B cells 50, 100, 200, 400 mg/L 24 hours To assess the effect of NNK on the viability of BEAS-2B cells, results showed that NNK reduced cell viability in a dose-dependent manner iScience. 2022 Dec 2;26(1):105708
H1299 cells 100 pM 24 hours NNK significantly enhances migration and invasion of H1299 cells and accelerates wound healing. Cancer Lett. 2012 May 1;318(1):106-13
B-Vector cells 265.04 µM 24 hours Evaluate the cytotoxicity of NNK in B-Vector cells, results showed B-Vector cells were moderately sensitive to NNK Molecules. 2022 Jul 29;27(15):4851
B-2A13 cells 24.52 µM 24 hours Evaluate the cytotoxicity of NNK in B-2A13 cells, results showed B-2A13 cells were more sensitive to NNK Molecules. 2022 Jul 29;27(15):4851
BEAS-2B cells 376.14 µM 24 hours Evaluate the cytotoxicity of NNK in BEAS-2B cells, results showed BEAS-2B cells were less sensitive to NNK Molecules. 2022 Jul 29;27(15):4851
FaDu (human hypopharyngeal squamous cancer cells) 1 µM and 2 µM 24 hours To investigate the effect of NNK on MSH2 and MLH1 protein and mRNA expression in FaDu cells. Results showed that NNK significantly upregulated miR-21 and miR-155, downregulated miR-422a, and reduced MSH2 and MLH1 protein and mRNA expression. Inhibition of miR-21 restored NNK-induced reduction in MSH2 expression. Cells. 2020 Apr 21;9(4):1031
NCI-H1703 (human lung squamous cancer cells) 1 µM and 2 µM 24 hours To investigate the effect of NNK on MSH2 and MLH1 protein and mRNA expression in NCI-H1703 cells. Results showed that NNK significantly upregulated miR-21 and miR-155, downregulated miR-422a, and reduced MSH2 and MLH1 protein and mRNA expression. Inhibition of miR-21 restored NNK-induced reduction in MSH2 expression. Cells. 2020 Apr 21;9(4):1031
Het-1A cells 1 µM 24 hours NNK stimulated expression of oncogenic genes, including ETS1, NRAS and SRC, which could be abolished in the presence of rSLURP-1. Life Sci. 2012 Nov 27;91(21-22):1122-5
BEP2D cells 1 µM 24 hours NNK stimulated expression of oncogenic genes, including MYB and PIK3CA, which could be abolished in the presence of rSLURP-1. Life Sci. 2012 Nov 27;91(21-22):1122-5
MRC-5 cells 10 µM 24, 48, and 72 hours NNK treatment significantly reduced GRα mRNA and protein expression levels and caused accumulation of DNMT1 at GR promoters 1B and 1F Sci Rep. 2018 Mar 20;8(1):4903
Panc-1 1 µM 24-48 hours NNK significantly enhanced the colony formation ability and spherogenesis of pancreatic cancer cells, while increasing the expression levels of stem cell markers OCT-4, SOX-2, and Nanog. Mol Oncol. 2022 Aug;16(15):2881-2895
BxPC-3 1 µM 24-48 hours NNK significantly enhanced the colony formation ability and spherogenesis of pancreatic cancer cells, while increasing the expression levels of stem cell markers OCT-4, SOX-2, and Nanog. Mol Oncol. 2022 Aug;16(15):2881-2895
NCI-H23 cells 10 µM 28 days To study the role of TCTP in NNK-induced EMT, results showed up-regulation of TCTP and vimentin expression J Transl Med. 2020 Feb 11;18(1):66
Bet1A cells 10 µM 28 days To study the role of TCTP in NNK-induced EMT, results showed up-regulation of TCTP and vimentin expression J Transl Med. 2020 Feb 11;18(1):66
Beas-2B 10 µM 6 hours DNMT1 protein returned to basal levels 2–6 hours after discontinuation of NNK treatment J Clin Invest. 2010 Feb;120(2):521-32
LLC 25 µM 72 hours NNK significantly upregulated IDO1 expression but did not affect IDO2, TDO, or TPH1 expression. Signal Transduct Target Ther. 2022 Sep 7;7(1):311
EPLC-32M 25 µM 72 hours NNK significantly upregulated IDO1 expression but did not affect IDO2, TDO, or TPH1 expression. Signal Transduct Target Ther. 2022 Sep 7;7(1):311
A549 25 µM 72 hours NNK significantly upregulated IDO1 expression but did not affect IDO2, TDO, or TPH1 expression. Signal Transduct Target Ther. 2022 Sep 7;7(1):311
16HBE 25 µM 72 hours NNK significantly upregulated IDO1 expression but did not affect IDO2, TDO, or TPH1 expression. Signal Transduct Target Ther. 2022 Sep 7;7(1):311
CAL-27 cells 5 µM 96 hours NNK stimulates DEPDC1 expression by promoting the methylation of its gene body through increased DNMT1 expression in OSCC cells. Am J Cancer Res. 2020 Jun 1;10(6):1745-1760
HSC-3 cells 5 µM 96 hours NNK stimulates DEPDC1 expression by promoting the methylation of its gene body through increased DNMT1 expression in OSCC cells. Am J Cancer Res. 2020 Jun 1;10(6):1745-1760
2B-NNK cells 100 mg/L multiple exposures To evaluate the effect of RRM2-C2orf48 overexpression on NNK-induced malignant transformation of BEAS-2B cells, results showed that RRM2-C2orf48 overexpression accelerated malignant transformation iScience. 2022 Dec 2;26(1):105708

NNK 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Fischer 344 rats Isolated perfused rat lung (IPRL) model Perfusion 0.1 μM and 1.2 μM Single perfusion, lasting 180 minutes To study the metabolism of NNK in the lung and the formation of DNA adducts, it was found that NNK is metabolized in the lung primarily through detoxification pathways, with approximately 55% of metabolites formed through detoxification pathways and roughly 30% through bioactivation pathways. The addition of PEITC significantly reduced the formation of oxidative metabolites and increased the formation of NNAL and the percentage of unmetabolized NNK. PEITC also significantly decreased the formation of DNA adducts in the lung tissue. Drug Metab Dispos. 2010 May;38(5):752-60
Mice NNK-induced lung cancer model and K-rasLA1 transgenic mice Intravenous injection 10 μM Once a week for 13 weeks (NNK model) or 5 weeks (K-rasLA1 model) MiR-124 agomiR significantly suppressed NNK-induced and K-ras mutation-driven lung tumorigenesis Mol Ther Nucleic Acids. 2017 Dec 15;9:145-154
A/J mice NNK-induced lung adenocarcinoma model Intraperitoneal injection 100 mg/kg Every other day, three times, lasting for 16 weeks NNK promoted lung adenocarcinoma development through CD36. iScience. 2023 Jul 27;26(8):107477
A/J mice A/J mice Intraperitoneal injection 100 mg/kg Single injection To evaluate the protective effect of HB diet against NNK-induced lung tumorigenesis, results showed HB downregulated cyp2a4 and cyp2a5 mRNA expression and facilitated the formation of non-carcinogenic NNK metabolites Pharmaceuticals (Basel). 2024 Nov 30;17(12):1615
Mice Pten +/− mice Intraperitoneal injection 100 mg/kg Single dose or three doses weekly, lasting 16-24 weeks To evaluate the effect of NNK on lung tumorigenesis in Pten +/? mice. Results showed that in lung tumor-susceptible pseudo–A/J mice, NNK treatment led to increased lung tumor size in Pten +/? mice but did not increase tumor multiplicity. In lung tumor-resistant C57BL/6 mice, NNK treatment did not induce lung tumors. Neoplasia. 2008 Aug;10(8):866-72
A/J and C3H mice Lung tumor model Intraperitoneal injection 100 mg/kg/day Every other day for three doses To study the effect of NNK on lung tumorigenesis in A/J and C3H mice. Results showed that NNK induced lung tumors in A/J mice but not in C3H mice. Am J Respir Cell Mol Biol. 2007 Jan;36(1):13-9
A/J mice Lung adenoma model Intraperitoneal injection 2 mg Single injection, terminated 24 weeks after treatment NNK induced increased expression levels of DNMT1, p-AKTser473, p-GSK3βser9, cytoplasmic hnRNP-U, and cytoplasmic βTrCP proteins J Clin Invest. 2010 Feb;120(2):521-32
Mice Agt+/+ and Agt+/- mice Oral gavage 3 μmol Twice a week for 20 weeks NNK significantly increased the multiplicity, volume, and load of lung tumor nodules, and these changes were significantly suppressed in Agt+/- mice. Exp Mol Med. 2023 Jun;55(6):1131-1144
A/J mice NNK-induced lung cancer model Injection 50 mg/kg Twice, one week apart, for 20 weeks To compare the efficacy of different fat types in ketogenic diets in preventing NNK-induced lung cancer. Results showed that the fish oil-enriched ketogenic diet (FO-KD) was most effective in reducing lung nodule numbers. Sci Rep. 2024 Mar 7;14(1):5610
A/J mice Lung cancer model Gavage 50 mg/kg Twice a week for 5 weeks NNK significantly upregulated IDO1 expression in lung tissues and reduced CD8+T cells while increasing Tregs. Signal Transduct Target Ther. 2022 Sep 7;7(1):311
Ferrets (Mustela putorius furo) Human lung cancer model Intraperitoneal injection 50 mg/kg Once a month for four consecutive months, followed by observation for 24, 26, and 32 weeks To investigate whether NNK exposure alone induces both preneoplastic and neoplastic lesions in ferret lungs. Results showed that NNK exposure led to preneoplastic lesions (squamous metaplasia, dysplasia, and atypical adenomatous hyperplasia) and tumors (squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinoma) in ferret lungs, with tumor incidence being time-dependent (16.7%, 40.0%, and 66.7% at 24, 26, and 32 weeks, respectively). Additionally, NNK exposure significantly increased α7 nAChR protein expression and showed a tendency for increased phospho-ERK and cyclin D1 protein levels. Lung Cancer. 2013 Dec;82(3):390-6
A/J mice NNK-induced lung cancer model Intraperitoneal injection 50 mg/kg Two injections, one week apart, for 20 weeks To investigate the inhibitory effect of soy saponins and isoflavones on NNK-induced lung nodule formation. Results showed that the combination of soy saponins and isoflavones significantly reduced the number of lung nodules and increased plasma isoflavone levels. Sci Rep. 2025 Apr 13;15(1):12714

NNK 动物研究

Animal study 肺肿瘤模型[3]
动物:A/J小鼠。
给药:100 mg/kg 在 0.1mL PBS 中 , 腹腔注射 ,每隔三天注射三剂 NNK。

NNK 参考文献

[1]Jin Z, et al. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone promotes functional cooperation of Bcl2 and c-Myc through phosphorylation in regulating cell survival and proliferation. J Biol Chem. 2004;279(38):40209-40219.

[2]Castonguay A, et al. Lung tumorigenicity of NNK given orally to A/J mice: its application to chemopreventive efficacy studies. Exp Lung Res. 1991;17(2):485-499.

[3]Razani-Boroujerdi S, Sopori ML. Early manifestations of NNK-induced lung cancer: role of lung immunity in tumor susceptibility. Am J Respir Cell Mol Biol. 2007 Jan;36(1):13-9.

NNK 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.83mL

0.97mL

0.48mL

24.13mL

4.83mL

2.41mL

48.26mL

9.65mL

4.83mL

NNK 技术信息

CAS号64091-91-4
分子式C10H13N3O2
分子量 207.23
SMILES Code O=C(C1=CC=CN=C1)CCCN(N=O)C
MDL No. MFCD00274580
别名
运输蓝冰
InChI Key FLAQQSHRLBFIEZ-UHFFFAOYSA-N
Pubchem ID 47289
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Inert atmosphere, 2-8°C

溶解方案

DMSO: 60 mg/mL(289.53 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

配制的工作液建议现用现配,短期内尽快用完。 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。